Most comprehensive health insurance policies in India cover cancer surgery including hospitalisation, surgeon fees, anaesthesia, theatre charges, chemotherapy and radiation therapy within the sum insured. Cancer-specific plans go further and offer lump-sum payouts on diagnosis in addition to treatment coverage. What actually gets paid depends on the sum insured, the waiting period clause, whether the hospital is on the insurer’s network and whether the specific treatment or drug is listed as covered under the policy terms.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India,
“Insurance confirmation before admission matters more than most patients realise. The time to check what is covered is before the surgery is scheduled, not after the bill arrives.”

Most comprehensive health policies and cancer-specific plans cover the core components of cancer surgical treatment within the stated sum insured limits.

• Surgery and Hospitalisation: Cancer surgery including lumpectomy, mastectomy, colectomy, robotic resection and HIPEC is covered under most comprehensive health policies and robotic cancer surgery at KIMS Hospital, Bangalore is included as a minimally invasive surgical procedure under most standard health insurance policies.
• Chemotherapy and Radiation: Pre-operative and post-operative chemotherapy and radiation therapy are covered under most plans including daycare chemotherapy sessions that don’t require overnight hospitalisation, though individual drug costs vary by policy.
• Diagnostic Tests: PET scan, CT scan, MRI, biopsy and tumour marker blood tests ordered as part of cancer staging and treatment monitoring are covered under most plans as diagnostic procedures linked to an active hospitalisation or treatment episode.
• Post-operative Follow-Up: Most comprehensive plans cover post-surgical follow-up consultations and surveillance scans within the policy period, though some plans cap follow-up coverage at a fixed number of visits or a fixed rupee amount per policy year.

Confirming what your specific policy covers before the first surgical consultation avoids billing surprises that arrive when the patient is least equipped to deal with them.

Several common exclusions catch patients off-guard and checking these before surgery is booked removes the risk of unexpected out-of-pocket costs.

• Waiting Period Exclusions: Most cancer insurance policies have an initial waiting period of 90 days during which no claims are accepted and breast cancer treatment or any other cancer surgery booked before this period ends will not be covered regardless of when the diagnosis was made.
• Pre-existing Cancer Exclusion: A cancer diagnosed before the policy was taken out is typically excluded from coverage or subject to a separate longer waiting period under most standard health insurance plans in India.
• Robotic Surgery Sub-limits: Some policies apply sub-limits specifically to robotic or laparoscopic surgery procedures and patients should confirm whether their policy covers the full robotic surgery cost or applies a conventional surgery rate to the claim.
• Targeted Therapy and Immunotherapy Drugs: Trastuzumab, pembrolizumab and other high-cost targeted or immunotherapy drugs are frequently excluded or sub-limited in standard health policies and require specific confirmation with the insurer before treatment begins rather than after the prescription is written.

Checking these four points with your insurer before the surgical consultation is scheduled prevents the financial surprises that derail treatment plans mid-course and for more on making informed cancer treatment decisions, our blog on second opinion in cancer diagnosis covers this in detail.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to cancer surgery across all types and stages at KIMS Hospital, Bangalore. He heads Oncology Services across Karnataka with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Patients wanting clarity on what their insurance covers before committing to a surgical plan are seen here with every decision going through tumour board review. Call +91 8104310753 to book your consultation.

Reference Links-

1. National Cancer Institute — Cancer Treatment and Insurance
2. Star Health Insurance — Cancer Insurance Plans India

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

Consultation fees for a surgical oncologist in Bangalore run between INR 500 and INR 1,500 at most private specialist centres depending on experience, hospital tier and whether it’s a first visit or a follow-up. Senior surgical oncologists with subspecialty training, high operative volumes and published research typically charge INR 1,000 to 1,500 per consultation. The consultation fee is just the starting point. What follows it, diagnostics, biopsy, surgery and adjuvant treatment, is where the real cost sits and understanding each component before the first appointment removes a significant amount of financial uncertainty from an already difficult situation.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India,
“The first appointment should answer three things. What is it, what stage is it and what does the treatment plan look like from here. A clear answer to all three is what a surgical oncologist consultation should deliver, not a vague plan to run more tests.”

Fees vary by experience, hospital category and nature of the visit but the consultation cost is a small fraction of the total treatment cost for most cancer cases.

• Initial Consultation: First consultations at private specialist centres in Bangalore cost INR 500 to 1,500 with senior surgical oncologists at high-volume hospitals like KIMS at the upper end and general oncology clinics sitting at the lower end of that range.
• Follow-up Fees: Follow-up consultations typically cost INR 300 to 800 at most centres and minimally invasive cancer surgery specialists who run structured post-operative review programmes include follow-ups as part of a broader care package rather than billing each visit independently.
• Hospital vs Clinic: Consulting a surgical oncologist inside a multi-specialty private hospital adds an institutional registration fee of INR 200 to 500 on top of the consultation, whereas consulting at an independent oncology clinic like MACS typically has a cleaner single fee structure without additional registration charges.
• Telemedicine Fees: Video consultations with senior surgical oncologists in Bangalore run INR 500 to 1,000 and are particularly useful for out-of-state or international patients who want a specialist opinion before travelling to Bangalore for the operative consultation and surgery.

Consultation fees are transparent at most specialist centres in Bangalore and asking for the fee structure before booking removes any uncertainty about what the first appointment will cost.

The consultation opens the treatment plan. Several cost components follow it and patients who understand these upfront plan their finances with far less stress.

• Diagnostic Workup: Blood tests, biopsy, CT scan, PET scan and pathology together cost INR 15,000 to 60,000 depending on which tests the surgical oncologist orders at the first visit, and this diagnostic package is typically confirmed in full before any treatment is booked or priced.
• Surgical Fee: The surgeon’s operative fee sits separate from hospital and theatre charges in most private hospital billing structures in Bangalore and robotic cancer surgery or conventional oncological resection packages at KIMS Hospital are provided as all-inclusive quotes covering the surgical team, anaesthesia, theatre and post-operative ward stay.
• Tumour Board Fee: Some specialist oncology centres charge a nominal tumour board review fee of INR 500 to 1,000 for multidisciplinary case review but most high-volume oncology centres in Bangalore include this in the consultation or surgical package rather than billing it separately.
• Long-term Follow-Up: Cancer patients need surveillance imaging every three to six months for the first two to three years after surgery and budgeting INR 5,000 to 15,000 per review cycle for scans and consultation is realistic for structured oncological follow-up at a private specialist centre in Bangalore.

Understanding the full cost structure from consultation through to follow-up is what allows families to plan without financial surprises appearing mid-treatment and for more on choosing the right surgical oncologist in Bangalore, our blog on minimally invasive cancer surgery covers this in detail.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to every surgical oncology consultation at KIMS Hospital, Bangalore. He heads Oncology Services across Karnataka with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Patients wanting a transparent consultation covering diagnosis, staging and a clear treatment plan are seen here with every case reviewed through tumour board. Call +91 8104310753 to book your consultation.

Reference Links-

1. Practo — Surgical Oncologist Fees Bangalore
2. Credihealth — Best Surgical Oncologists Bangalore 2025

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

Robotic cancer surgery in India costs between INR 1,50,000 and 8,00,000 depending on cancer type, operative complexity and which hospital you’re at. The da Vinci platform adds INR 50,000 to 1,50,000 over conventional laparoscopy at most specialist centres. That premium pays for a 3D magnified operative field, wristed instruments with far greater range of motion than the human hand, less blood loss and a faster return to adjuvant treatment. Whether it’s worth it depends entirely on where the tumour is, how complex the dissection needs to be and what conventional surgery actually achieves in that specific situation.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India,
“Robotic surgery isn’t right for every cancer operation. But for tumours in confined spaces where precision determines whether a patient needs re-operation, the platform cost is easily justified by what the outcome looks like.”

Cost shifts considerably by procedure type, cancer site and hospital tier. India’s pricing stays a fraction of what the same operation costs in Western countries.

• Procedure Range: Simpler robotic procedures start at INR 1,50,000 while complex oncological resections reach INR 7,50,000 to 8,00,000 and robotic cancer surgery at KIMS Hospital, Bangalore bundles the full surgical team, da Vinci platform time, theatre charges and post-operative care into one package rather than billing each element separately.
• The Platform Surcharge: Da Vinci adds INR 50,000 to 1,50,000 above conventional laparoscopic charges at equipped centres. That reflects theatre time on the robotic platform and disposable instrument costs, not an extra surgeon premium on top of the standard operative fee.
• India vs Abroad: Same robotic cancer operation in the USA costs USD 20,000 to 30,000 or more. India delivers equivalent surgical technique, the same da Vinci platform and comparable specialist training at INR 3 to 8 lakhs. No clinical compromise. Just a structural cost difference.
• Insurance: Most comprehensive health policies cover robotic surgery as a minimally invasive procedure and patients should confirm sub-limits and pre-authorisation requirements with their insurer before admission because some plans apply restrictions to robotic procedures specifically.

Cost alone is the wrong frame for evaluating this. The right question is what the platform actually achieves clinically for that tumour location and whether conventional alternatives get you to the same place.

That depends on the cancer type, the tumour’s location and what the robotic platform specifically enables in that operative context.

• Where It Genuinely Helps: Prostate, rectal, gynaecological and head and neck cancers in confined pelvic or transoral spaces benefit most. Wristed instruments, 3D magnification and tremor filtration improve margin quality and reduce nerve injury in ways conventional laparoscopy can’t consistently match in those anatomical locations.
• Recovery Speed Matters: Robotic patients typically go home one to two days earlier than open surgery patients and return to adjuvant chemotherapy or radiation faster. In aggressive cancer subtypes where treatment timing affects outcomes, that difference directly offsets the platform cost in the overall clinical picture.
• Not Every Case Needs It: Simple lumpectomy, straightforward laparoscopic colon resection and operations where conventional technique reliably achieves clear margins without complication don’t need the robotic platform and adding the surcharge for those cases isn’t clinically justified.
• Surgeon Volume Decides: The platform produces better results in high-volume robotic hands. A specialist performing 100 robotic cases a year at a dedicated oncology centre outperforms a low-volume surgeon using the same equipment and this difference in outcome is what actually justifies the cost, not the machine itself.

Worth comes down to whether the platform changes what’s surgically achievable for your specific tumour and for more on robotic surgery costs specific to Bangalore, our blog on robotic surgery cost covers this in detail.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to robotic cancer surgery at KIMS Hospital, Bangalore. He heads Oncology Services across Karnataka with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Patients wanting clarity on whether robotic surgery fits their case and what it will cost are seen here with every decision going through tumour board review. Call +91 8104310753 to book your consultation.

Reference Links-

1. National Cancer Institute — Robotic Surgery in Cancer Treatment
2. Medsurge India — Robotic Surgery Cost India 2025

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

HIPEC in Bangalore runs INR 4,10,000 to 6,25,000 for standard cases at private specialist centres. Complex cases push that to INR 8,00,000 to 10,00,000 or beyond. Two things happen in one operative session. Cytoreductive surgery removes all visible tumour from the peritoneal cavity. Immediately after, heated chemotherapy is circulated through the abdomen for 60 to 90 minutes to destroy what remains. The final bill depends on three things: how much tumour the team has to remove, which chemotherapy drug is used for the peritoneal wash and how many days the patient needs ICU and ward care after.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India,
“HIPEC looks expensive on paper. But patients on repeated IV chemotherapy for peritoneal disease often spend INR 8 to 15 lakhs across multiple lines with worse outcomes. The total cost over time frequently works out lower with HIPEC.”

The cost isn’t one number. It’s several components that add up differently for every patient depending on disease burden and recovery.

• Surgical Component: Cytoreductive surgery alone runs INR 1,50,000 to 3,00,000 based on operative extent and HIPEC treatment at high-volume centres like KIMS Hospital, Bangalore bundles the surgical team, anaesthesia, theatre time and perfusion equipment into a single operative package rather than billing each element separately.
• Drug Costs: Mitomycin C, oxaliplatin and cisplatin are the three most commonly used agents and drug cost per case runs INR 30,000 to 1,50,000, the variation driven by which drug is chosen, the dose calculated from body surface area and whether the oncology team uses a combination regimen for that specific cancer type.
• ICU and Ward Stay: One to two ICU days cost INR 15,000 to 25,000 per day. Six to twelve ward days add INR 8,000 to 15,000 per day on top. For complex cases needing extended monitoring, the hospital stay component alone can add INR 1,50,000 to 3,00,000 to what would otherwise be a standard HIPEC bill.
• Pre-operative Tests: CT scan, PET scan, blood panel, cardiac review and anaesthesia assessment together cost INR 30,000 to 70,000 and in most private hospital billing structures in Bangalore, these sit entirely outside the surgical package as a separate pre-admission expense.

The Peritoneal Cancer Index score is the single biggest cost predictor. Higher PCI means more tumour, longer surgery, higher equipment use and a longer stay.

Several factors outside the operative itself move the final number up or down in ways patients don’t always anticipate before admission.

• PCI Score: Low PCI means faster surgery, earlier discharge and a bill closer to the base range while high PCI adds INR 2,00,000 to 4,00,000 through longer operative time and extended post-operative monitoring and robotic cancer surgery or laparoscopic HIPEC in carefully selected low-PCI patients reduces recovery duration and cuts the ward stay component of the total bill.
• Insurance: Most comprehensive health policies cover HIPEC since it combines surgery and chemotherapy in one session, but coverage terms vary and patients should confirm their specific plan’s position on HIPEC before admission rather than after the bill arrives.
• India vs Abroad: The same procedure in the USA or UK runs USD 50,000 or more. Bangalore’s INR 4 to 10 lakh range is a fraction of that without any reduction in surgical technique, drug quality or post-operative care at specialist centres.
• Government Schemes: Ayushman Bharat and Karnataka state cancer programmes cover HIPEC at select empanelled centres and eligible patients who apply before admission can have the out-of-pocket cost reduced substantially or removed entirely depending on the scheme and case eligibility.

Getting a full itemised estimate before admission removes financial uncertainty from an already difficult decision and for more on what the surgical component of HIPEC involves, our blog on cytoreductive surgery covers this in detail.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to HIPEC and cytoreductive surgery at KIMS Hospital, Bangalore. He has performed over 50 HIPEC procedures in the past five years, heads Oncology Services across Karnataka with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Patients wanting a full cost estimate covering cytoreduction, drug costs, ICU days and recovery before committing to treatment are seen here with every case reviewed through tumour board. Call +91 8104310753 to book your consultation.

Reference Links-

1. National Cancer Institute — HIPEC and Peritoneal Cancer
2. LoginToHealth — HIPEC Cost in Bangalore

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

For breast cancer surgery in Bangalore, the right surgical oncologist has specialist oncology training rather than general surgery training, operates at high volume, works within a multidisciplinary tumour board and has a documented track record across lumpectomy, mastectomy, oncoplastic techniques and reconstruction. Prof. Dr. Sandeep Nayak meets all of these. With 24 years in surgical oncology, DNB qualifications in both Surgical Oncology and General Surgery, a fellowship in Laparoscopic and Robotic Onco-Surgery and originator credits for RABIT, MIND and L-VEIL techniques, he is one of the most experienced breast cancer surgical oncologists currently operating in Bangalore.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India,
“The best breast cancer surgeon for any patient is the one who offers the full range of surgical options, takes every case to tumour board and never plans an operation in isolation from the systemic treatment team.”

Choosing the right surgeon for breast cancer isn’t just about reputation. It’s about specific clinical capabilities that directly affect surgical outcomes.

• Specialist Training: A surgical oncologist with a specific DNB or fellowship in oncological surgery has training that a general surgeon or gynaecologist operating on breast cancer doesn’t carry and breast cancer treatment at specialist oncology centres in Bangalore consistently produces better margin clearance rates than non-specialist surgical settings.
• Full Operative Range: The right surgeon offers lumpectomy, mastectomy, sentinel node biopsy, axillary dissection, oncoplastic techniques and reconstruction in the same practice rather than referring out for any of these, which matters when the surgical plan needs to change intraoperatively based on findings.
• Tumour Board Practice: Every breast cancer case should go through a multidisciplinary tumour board before the surgical plan is confirmed and a surgeon who operates without that collective review is making treatment decisions that should involve medical oncology, radiation oncology and pathology input.
• Published Research and Innovation: Surgeons who publish clinical research, develop new techniques and contribute to peer-reviewed literature have a different level of engagement with their specialty than those who don’t and this is directly reflected in how current their operative approach is.

Operative volume, specialist qualifications and tumour board practice are the three most clinically meaningful criteria for selecting a breast cancer surgical oncologist in Bangalore.

Twenty-four years of surgical oncology experience, specific DNB qualifications and documented technique innovation set the clinical standard for breast cancer surgery in Bangalore.

• Specialist Credentials: DNB in Surgical Oncology and General Surgery combined with a fellowship in Laparoscopic and Robotic Onco-Surgery, completing the specialist training pathway that separates surgical oncologists from general surgeons performing breast operations and robotic cancer surgery at KIMS Hospital, Bangalore is part of the standard operative offering for appropriate cases.
• Technique Innovation: Originator of RABIT, MIND and L-VEIL operative techniques — published surgical approaches developed and refined through over 25 peer-reviewed clinical studies, representing a level of contribution to the field that most breast cancer surgeons in Bangalore don’t carry.
• High-Volume Tumour Board: Every patient is seen through the full multidisciplinary tumour board at KIMS Hospital, Bangalore with surgical oncology, medical oncology, radiation oncology and pathology all contributing to the treatment plan before any operation is confirmed or booked.
• Karnataka Oncology Leadership: Head of Oncology Services across Karnataka and Executive Director of Surgical Oncology at KIMS Hospital, Bangalore, a leadership role that reflects both clinical standing and the trust placed in his judgement across the state’s most complex oncology cases.

For more on how specialist centres approach thyroid and other cancer types in Bangalore, our blog on thyroid cancer treatment in Bangalore covers specialist oncology in the city in detail.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to breast cancer surgery across all stages and presentations at KIMS Hospital, Bangalore. He heads Oncology Services across Karnataka with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Patients wanting a specialist breast cancer surgical assessment with full tumour board review are seen here before any surgical plan is confirmed. Call +91 8104310753 to book your consultation.

Reference Links-

1. National Cancer Institute — Choosing a Cancer Doctor
2. World Health Organization — Breast Cancer Treatment

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.